These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38969436)

  • 1. Bridging Psilocybin-Induced Changes in the Brain's Dynamic Functional Connectome With an Individual's Subjective Experience.
    Singleton SP; Kuceyeski A
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2024 Jul; 9(7):637-638. PubMed ID: 38969436
    [No Abstract]   [Full Text] [Related]  

  • 2. Dynamic Functional Hyperconnectivity After Psilocybin Intake Is Primarily Associated With Oceanic Boundlessness.
    Mortaheb S; Fort LD; Mason NL; Mallaroni P; Ramaekers JG; Demertzi A
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2024 Jul; 9(7):681-692. PubMed ID: 38588855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin.
    Lord LD; Expert P; Atasoy S; Roseman L; Rapuano K; Lambiotte R; Nutt DJ; Deco G; Carhart-Harris RL; Kringelbach ML; Cabral J
    Neuroimage; 2019 Oct; 199():127-142. PubMed ID: 31132450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural Mechanisms of Resting-State Networks and the Amygdala Underlying the Cognitive and Emotional Effects of Psilocybin.
    Stoliker D; Novelli L; Vollenweider FX; Egan GF; Preller KH; Razi A
    Biol Psychiatry; 2024 Jul; 96(1):57-66. PubMed ID: 38185235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A qualitative report on the subjective experience of intravenous psilocybin administered in an FMRI environment.
    Turton S; Nutt DJ; Carhart-Harris RL
    Curr Drug Abuse Rev; 2014; 7(2):117-27. PubMed ID: 25563444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals.
    McCulloch DE; Madsen MK; Stenbæk DS; Kristiansen S; Ozenne B; Jensen PS; Knudsen GM; Fisher PM
    J Psychopharmacol; 2022 Jan; 36(1):74-84. PubMed ID: 34189985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.
    Carhart-Harris RL; Erritzoe D; Williams T; Stone JM; Reed LJ; Colasanti A; Tyacke RJ; Leech R; Malizia AL; Murphy K; Hobden P; Evans J; Feilding A; Wise RG; Nutt DJ
    Proc Natl Acad Sci U S A; 2012 Feb; 109(6):2138-43. PubMed ID: 22308440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis.
    Carhart-Harris RL; Leech R; Erritzoe D; Williams TM; Stone JM; Evans J; Sharp DJ; Feilding A; Wise RG; Nutt DJ
    Schizophr Bull; 2013 Nov; 39(6):1343-51. PubMed ID: 23044373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives.
    Pallavicini C; Vilas MG; Villarreal M; Zamberlan F; Muthukumaraswamy S; Nutt D; Carhart-Harris R; Tagliazucchi E
    Neuroimage; 2019 Oct; 200():281-291. PubMed ID: 31247301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hallucinogen actions on human brain revealed.
    Lee HM; Roth BL
    Proc Natl Acad Sci U S A; 2012 Feb; 109(6):1820-1. PubMed ID: 22308478
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparing Neural Correlates of Consciousness: From Psychedelics to Hypnosis and Meditation.
    Moujaes F; Rieser NM; Phillips C; de Matos NMP; Brügger M; Dürler P; Smigielski L; Stämpfli P; Seifritz E; Vollenweider FX; Anticevic A; Preller KH
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2024 May; 9(5):533-543. PubMed ID: 37459910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain's control energy landscape.
    Singleton SP; Luppi AI; Carhart-Harris RL; Cruzat J; Roseman L; Nutt DJ; Deco G; Kringelbach ML; Stamatakis EA; Kuceyeski A
    Nat Commun; 2022 Oct; 13(1):5812. PubMed ID: 36192411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced repertoire of brain dynamical states during the psychedelic experience.
    Tagliazucchi E; Carhart-Harris R; Leech R; Nutt D; Chialvo DR
    Hum Brain Mapp; 2014 Nov; 35(11):5442-56. PubMed ID: 24989126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroimaging: a scanner, colourfully.
    Roiser JP; Rees G
    Curr Biol; 2012 Apr; 22(7):R231-3. PubMed ID: 22497939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased directed functional connectivity in the psychedelic state.
    Barnett L; Muthukumaraswamy SD; Carhart-Harris RL; Seth AK
    Neuroimage; 2020 Apr; 209():116462. PubMed ID: 31857204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: Contributions of the resting brain.
    Müller F; Liechti ME; Lang UE; Borgwardt S
    Prog Brain Res; 2018; 242():159-177. PubMed ID: 30471679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High dose psilocybin is associated with positive subjective effects in healthy volunteers.
    Nicholas CR; Henriquez KM; Gassman MC; Cooper KM; Muller D; Hetzel S; Brown RT; Cozzi NV; Thomas C; Hutson PR
    J Psychopharmacol; 2018 Jul; 32(7):770-778. PubMed ID: 29945469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psilocybin: Good Trip or Bad Trip.
    Sellers EM
    Clin Pharmacol Ther; 2017 Oct; 102(4):580-584. PubMed ID: 28548221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin.
    Lebedev AV; Lövdén M; Rosenthal G; Feilding A; Nutt DJ; Carhart-Harris RL
    Hum Brain Mapp; 2015 Aug; 36(8):3137-53. PubMed ID: 26010878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding.
    Madsen MK; Fisher PM; Stenbæk DS; Kristiansen S; Burmester D; Lehel S; Páleníček T; Kuchař M; Svarer C; Ozenne B; Knudsen GM
    Eur Neuropsychopharmacol; 2020 Apr; 33():71-80. PubMed ID: 32146028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.